Ms. Oshinowo leads engagement work across a variety of practices at CBPartners. Her primary expertise is on early-stage pipeline issues related to commercial strategy, including competitive positioning, pricing, market access and trial design optimisation across a wide range of therapeutic areas. She routinely advises on business development and licensing decisions, as well as go / no-go pipeline advancement by clients around the world.
Prior to joining CBPartners, Ms. Oshinowo worked at KPMG, where she was a manager on the strategy team and led opportunity assessments and due diligence engagements to support mergers and acquisitions across the healthcare industry. She also has prior experience with PriceSpective / ICON and EASTON ASSOCIATES. Ms. Oshinowo holds an MSc in International Health Management from Imperial College London and a BSc (Hons) in Pharmacology from the University of Edinburgh.